Yüksel Ürün: Did you know the FDA approved cancer drugs target fewer than 200 proteins?

Yüksel Ürün shared a post on X:

“Did you know the FDA approved cancer drugs target fewer than 200 proteins?

• Integrating proteogenomics data from 1,043 patients identified new therapeutic targets.
• Analysis of 2,863 druggable proteins revealed key mRNA-protein correlations.
• Tumor proteomics and genetic screens uncovered druggable dependencies and synthetic lethality strategies.”

Source: Yüksel Ürün/X

Yüksel Ürün is a Medical Oncology professor at Ankara University School of Medicine in Turkey. His research focuses on genitourinary cancers, covering epidemiology, diagnosis, biomarkers, meta-analysis, and treatment outcomes. His dedication to patient care and research inspires positive change in the medical field.  .